Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Nektar Therapeutics
Business Segments
Business Segments
Depreciation And Amortization
Depreciation And Amortization
Nektar Therapeutics
·
Business Segments
·
1 segment
·
Rolls up to
D&A
Breakdown
Segments
Business Segments
View metric
Quarterly
Annual
TTM
Segment
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Business Segments
$394K
$181K
$163K
$161K
$121K
Total
$426K
$214K
$196K
$190K
$151K